Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Gene Modifying Immunotherapy for Blood Cancer Market Size Growth Rate by Type (2014-2025) 1.4.2 CAR T-cell Therapy 1.4.3 TCR T-cell Therapy 1.5 Market by Application 1.5.1 Global Gene Modifying Immunotherapy for Blood Cancer Market Share by Application (2019-2025) 1.5.2 Acute Lymphocytic Leukemia 1.5.3 Chronic Lymphocytic Leukemia 1.5.4 B Cell Lymphoma 1.5.5 Multiple Myeloma 1.5.6 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Gene Modifying Immunotherapy for Blood Cancer Market Size 2.2 Gene Modifying Immunotherapy for Blood Cancer Growth Trends by Regions 2.2.1 Gene Modifying Immunotherapy for Blood Cancer Market Size by Regions (2019-2025) 2.2.2 Gene Modifying Immunotherapy for Blood Cancer Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 3 Market Share by Key Players 3.1 Gene Modifying Immunotherapy for Blood Cancer Market Size by by Players 3.1.1 Global Gene Modifying Immunotherapy for Blood Cancer Revenue by by Players (2014-2019) 3.1.2 Global Gene Modifying Immunotherapy for Blood Cancer Revenue Market Share by by Players (2014-2019) 3.1.3 Global Gene Modifying Immunotherapy for Blood Cancer Market Concentration Ratio (CR5 and HHI) 3.2 Gene Modifying Immunotherapy for Blood Cancer Key Players Head office and Area Served 3.3 Key Players Gene Modifying Immunotherapy for Blood Cancer Product/Solution/Service 3.4 Date of Enter into Gene Modifying Immunotherapy for Blood Cancer Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2014-2019) 4.2 Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2014-2019) 5 North America 5.1 North America Gene Modifying Immunotherapy for Blood Cancer Market Size (2014-2019) 5.2 Gene Modifying Immunotherapy for Blood Cancer Key Players in North America 5.3 North America Gene Modifying Immunotherapy for Blood Cancer Market Size by Type 5.4 North America Gene Modifying Immunotherapy for Blood Cancer Market Size by Application 6 Europe 6.1 Europe Gene Modifying Immunotherapy for Blood Cancer Market Size (2014-2019) 6.2 Gene Modifying Immunotherapy for Blood Cancer Key Players in Europe 6.3 Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Type 6.4 Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Application 7 China 7.1 China Gene Modifying Immunotherapy for Blood Cancer Market Size (2014-2019) 7.2 Gene Modifying Immunotherapy for Blood Cancer Key Players in China 7.3 China Gene Modifying Immunotherapy for Blood Cancer Market Size by Type 7.4 China Gene Modifying Immunotherapy for Blood Cancer Market Size by Application 8 Japan 8.1 Japan Gene Modifying Immunotherapy for Blood Cancer Market Size (2014-2019) 8.2 Gene Modifying Immunotherapy for Blood Cancer Key Players in Japan 8.3 Japan Gene Modifying Immunotherapy for Blood Cancer Market Size by Type 8.4 Japan Gene Modifying Immunotherapy for Blood Cancer Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Gene Modifying Immunotherapy for Blood Cancer Market Size (2014-2019) 9.2 Gene Modifying Immunotherapy for Blood Cancer Key Players in Southeast Asia 9.3 Southeast Asia Gene Modifying Immunotherapy for Blood Cancer Market Size by Type 9.4 Southeast Asia Gene Modifying Immunotherapy for Blood Cancer Market Size by Application 10 India 10.1 India Gene Modifying Immunotherapy for Blood Cancer Market Size (2014-2019) 10.2 Gene Modifying Immunotherapy for Blood Cancer Key Players in India 10.3 India Gene Modifying Immunotherapy for Blood Cancer Market Size by Type 10.4 India Gene Modifying Immunotherapy for Blood Cancer Market Size by Application 11 Central & South America 11.1 Central & South America Gene Modifying Immunotherapy for Blood Cancer Market Size (2014-2019) 11.2 Gene Modifying Immunotherapy for Blood Cancer Key Players in Central & South America 11.3 Central & South America Gene Modifying Immunotherapy for Blood Cancer Market Size by Type 11.4 Central & South America Gene Modifying Immunotherapy for Blood Cancer Market Size by Application 12 International Players Profiles 12.1 Novartis 12.1.1 Novartis Company Details 12.1.2 Company Description and Business Overview 12.1.3 Gene Modifying Immunotherapy for Blood Cancer Introduction 12.1.4 Novartis Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019)) 12.1.5 Novartis Recent Development 12.2 Kite Pharma 12.2.1 Kite Pharma Company Details 12.2.2 Company Description and Business Overview 12.2.3 Gene Modifying Immunotherapy for Blood Cancer Introduction 12.2.4 Kite Pharma Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019) 12.2.5 Kite Pharma Recent Development 12.3 Juno Therapeutics 12.3.1 Juno Therapeutics Company Details 12.3.2 Company Description and Business Overview 12.3.3 Gene Modifying Immunotherapy for Blood Cancer Introduction 12.3.4 Juno Therapeutics Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019) 12.3.5 Juno Therapeutics Recent Development 12.4 Cellectis 12.4.1 Cellectis Company Details 12.4.2 Company Description and Business Overview 12.4.3 Gene Modifying Immunotherapy for Blood Cancer Introduction 12.4.4 Cellectis Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019) 12.4.5 Cellectis Recent Development 12.5 Ziopharm Oncology 12.5.1 Ziopharm Oncology Company Details 12.5.2 Company Description and Business Overview 12.5.3 Gene Modifying Immunotherapy for Blood Cancer Introduction 12.5.4 Ziopharm Oncology Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019) 12.5.5 Ziopharm Oncology Recent Development 12.6 Celyad 12.6.1 Celyad Company Details 12.6.2 Company Description and Business Overview 12.6.3 Gene Modifying Immunotherapy for Blood Cancer Introduction 12.6.4 Celyad Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019) 12.6.5 Celyad Recent Development 12.7 Bluebird Bio 12.7.1 Bluebird Bio Company Details 12.7.2 Company Description and Business Overview 12.7.3 Gene Modifying Immunotherapy for Blood Cancer Introduction 12.7.4 Bluebird Bio Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019) 12.7.5 Bluebird Bio Recent Development 12.8 Bellicum Pharmaceuticals 12.8.1 Bellicum Pharmaceuticals Company Details 12.8.2 Company Description and Business Overview 12.8.3 Gene Modifying Immunotherapy for Blood Cancer Introduction 12.8.4 Bellicum Pharmaceuticals Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019) 12.8.5 Bellicum Pharmaceuticals Recent Development 12.9 Mustang Bio 12.9.1 Mustang Bio Company Details 12.9.2 Company Description and Business Overview 12.9.3 Gene Modifying Immunotherapy for Blood Cancer Introduction 12.9.4 Mustang Bio Revenue in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019) 12.9.5 Mustang Bio Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Product (2019-2025) 13.2 Market Size Forecast by Application (2019-2025) 13.3 Market Size Forecast by Regions 13.4 North America 13.5 Europe 13.6 China 13.7 Japan 13.8 Southeast Asia 13.9 India 13.10 Central & South America 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 15.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Gene Modifying Immunotherapy for Blood Cancer Key Market Segments Table Key Players Gene Modifying Immunotherapy for Blood Cancer Covered Table Global Gene Modifying Immunotherapy for Blood Cancer Market Size Growth Rate by Type 2018-2025 (Million US$) Figuer CAR T-cell Therapy Figures Table Key Players of CAR T-cell Therapy Figuer TCR T-cell Therapy Figures Table Key Players of TCR T-cell Therapy Table Global Gene Modifying Immunotherapy for Blood Cancer Market Size Growth by Application 2019-2025 (Million US$) Figure Global Gene Modifying Immunotherapy for Blood Cancer Market Share by Application in 2018 & 2025 Figure Acute Lymphocytic Leukemia Case Studies Figure Chronic Lymphocytic Leukemia Case Studies Figure B Cell Lymphoma Case Studies Figure Multiple Myeloma Case Studies Figure Other Case Studies Figure Gene Modifying Immunotherapy for Blood Cancer Report Years Considered Figure Global Gene Modifying Immunotherapy for Blood Cancer Market Size and Growth Rate 2014-2025 (Million US$) Table Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Regions 2019-2025 (Million US$) Table Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Regions 2019-2025 (Million US$) Table Global Gene Modifying Immunotherapy for Blood Cancer Market Share by Regions 2014-2019 Figure Global Gene Modifying Immunotherapy for Blood Cancer Market Share by Regions 2014-2019 Figure Global Gene Modifying Immunotherapy for Blood Cancer Market Share by Regions in 2018 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure PORTER'S FIVE FORCES ANALYSIS Table Global Gene Modifying Immunotherapy for Blood Cancer Revenue by by Players (2014-2019) (Million US$) Table Global Gene Modifying Immunotherapy for Blood Cancer Market Share by by Players (2014-2019) Figure Global Gene Modifying Immunotherapy for Blood Cancer Market Share by by Players in 2018 Table Global Gene Modifying Immunotherapy for Blood Cancer by Players Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Gene Modifying Immunotherapy for Blood Cancer Product/Solution/Service Table Date of Enter into Gene Modifying Immunotherapy for Blood Cancer Market Table Mergers & Acquisitions, Expansion Plans Table Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Type (2014-2019) (Million US$) Table Global Gene Modifying Immunotherapy for Blood Cancer Market Size Share by Type (2014-2019) Figure Global Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Type (2014-2019) Table Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2014-2019) (Million US$) Table Global Gene Modifying Immunotherapy for Blood Cancer Market Size Share by Application (2014-2019) Figure Global Gene Modifying Immunotherapy for Blood Cancer Market Size Market Share by Application (2014-2019) Figure Global Gene Modifying Immunotherapy for Blood Cancer Revenue Market Share by Application in 2018 Figure North America Gene Modifying Immunotherapy for Blood Cancer Market Size 2014-2019 (Million US$) Table North America Key Players Gene Modifying Immunotherapy for Blood Cancer Revenue (2018-2019) (Million US$) Table North America Key Players Gene Modifying Immunotherapy for Blood Cancer Market Share (2018-2019) Table North America Gene Modifying Immunotherapy for Blood Cancer Market Size by Type 2014-2019 (Million US$) Table North America Gene Modifying Immunotherapy for Blood Cancer Market Share by Type 2014-2019 Table North America Gene Modifying Immunotherapy for Blood Cancer Market Size by Application 2014-2019 (Million US$) Table North America Gene Modifying Immunotherapy for Blood Cancer Market Share by Application 2014-2019 Figure Europe Gene Modifying Immunotherapy for Blood Cancer Market Size 2014-2019 (Million US$) Table Europe Key Players Gene Modifying Immunotherapy for Blood Cancer Revenue (2018-2019) (Million US$) Table Europe Key Players Gene Modifying Immunotherapy for Blood Cancer Market Share (2018-2019) Table Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Type 2014-2019 (Million US$) Table Europe Gene Modifying Immunotherapy for Blood Cancer Market Share by Type 2014-2019 Table Europe Gene Modifying Immunotherapy for Blood Cancer Market Size by Application 2014-2019 (Million US$) Table Europe Gene Modifying Immunotherapy for Blood Cancer Market Share by Application 2014-2019 Figure China Gene Modifying Immunotherapy for Blood Cancer Market Size 2014-2019 (Million US$) Table China Key Players Gene Modifying Immunotherapy for Blood Cancer Revenue (2018-2019) (Million US$) Table China Key Players Gene Modifying Immunotherapy for Blood Cancer Market Share (2018-2019) Table China Gene Modifying Immunotherapy for Blood Cancer Market Size by Type 2014-2019 (Million US$) Table China Gene Modifying Immunotherapy for Blood Cancer Market Share by Type 2014-2019 Table China Gene Modifying Immunotherapy for Blood Cancer Market Size by Application 2014-2019 (Million US$) Table China Gene Modifying Immunotherapy for Blood Cancer Market Share by Application 2014-2019 Figure Japan Gene Modifying Immunotherapy for Blood Cancer Market Size 2014-2019 (Million US$) Table Japan Key Players Gene Modifying Immunotherapy for Blood Cancer Revenue (2018-2019) (Million US$) Table Japan Key Players Gene Modifying Immunotherapy for Blood Cancer Market Share (2018-2019) Table Japan Gene Modifying Immunotherapy for Blood Cancer Market Size by Type 2014-2019 (Million US$) Table Japan Gene Modifying Immunotherapy for Blood Cancer Market Share by Type 2014-2019 Table Japan Gene Modifying Immunotherapy for Blood Cancer Market Size by Application 2014-2019 (Million US$) Table Japan Gene Modifying Immunotherapy for Blood Cancer Market Share by Application 2014-2019 Figure Southeast Asia Gene Modifying Immunotherapy for Blood Cancer Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Gene Modifying Immunotherapy for Blood Cancer Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Gene Modifying Immunotherapy for Blood Cancer Market Share (2018-2019) Table Southeast Asia Gene Modifying Immunotherapy for Blood Cancer Market Size by Type 2014-2019 (Million US$) Table Southeast Asia Gene Modifying Immunotherapy for Blood Cancer Market Share by Type 2014-2019 Table Southeast Asia Gene Modifying Immunotherapy for Blood Cancer Market Size by Application 2014-2019 (Million US$) Table Southeast Asia Gene Modifying Immunotherapy for Blood Cancer Market Share by Application 2014-2019 Figure India Gene Modifying Immunotherapy for Blood Cancer Market Size 2014-2019 (Million US$) Table India Key Players Gene Modifying Immunotherapy for Blood Cancer Revenue (2018-2019) (Million US$) Table India Key Players Gene Modifying Immunotherapy for Blood Cancer Market Share (2018-2019) Table India Gene Modifying Immunotherapy for Blood Cancer Market Size by Type 2014-2019 (Million US$) Table India Gene Modifying Immunotherapy for Blood Cancer Market Share by Type 2014-2019 Table India Gene Modifying Immunotherapy for Blood Cancer Market Size by Application 2014-2019 (Million US$) Table India Gene Modifying Immunotherapy for Blood Cancer Market Share by Application 2014-2019 Figure Central & South America Gene Modifying Immunotherapy for Blood Cancer Market Size 2014-2019 (Million US$) Table Central & South America Key Players Gene Modifying Immunotherapy for Blood Cancer Revenue (2018-2019) (Million US$) Table Central & South America Key Players Gene Modifying Immunotherapy for Blood Cancer Market Share (2018-2019) Table Central & South America Gene Modifying Immunotherapy for Blood Cancer Market Size by Type 2014-2019 (Million US$) Table Central & South America Gene Modifying Immunotherapy for Blood Cancer Market Share by Type 2014-2019 Table Central & South America Gene Modifying Immunotherapy for Blood Cancer Market Size by Application 2014-2019 (Million US$) Table Central & South America Gene Modifying Immunotherapy for Blood Cancer Market Share by Application 2014-2019 Table Novartis Company Details Table Novartis Revenue in Gene Modifying Immunotherapy for Blood Cancer Business 2014-2019 (Million US$) Figure Novartis Revenue Growth Rate in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019) Table Novartis Recent Development Table Kite Pharma Company Details Table Kite Pharma Revenue in Gene Modifying Immunotherapy for Blood Cancer Business 2014-2019 (Million US$) Figure Kite Pharma Revenue Growth Rate in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019) Table Kite Pharma Recent Development Table Juno Therapeutics Company Details Table Juno Therapeutics Revenue in Gene Modifying Immunotherapy for Blood Cancer Business 2014-2019 (Million US$) Figure Juno Therapeutics Revenue Growth Rate in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019) Table Juno Therapeutics Recent Development Table Cellectis Company Details Table Cellectis Revenue in Gene Modifying Immunotherapy for Blood Cancer Business 2014-2019 (Million US$) Figure Cellectis Revenue Growth Rate in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019) Table Cellectis Recent Development Table Ziopharm Oncology Company Details Table Ziopharm Oncology Revenue in Gene Modifying Immunotherapy for Blood Cancer Business 2014-2019 (Million US$) Figure Ziopharm Oncology Revenue Growth Rate in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019) Table Ziopharm Oncology Recent Development Table Celyad Company Details Table Celyad Revenue in Gene Modifying Immunotherapy for Blood Cancer Business 2014-2019 (Million US$) Figure Celyad Revenue Growth Rate in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019) Table Celyad Recent Development Table Bluebird Bio Company Details Table Bluebird Bio Revenue in Gene Modifying Immunotherapy for Blood Cancer Business 2014-2019 (Million US$) Figure Bluebird Bio Revenue Growth Rate in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019) Table Bluebird Bio Recent Development Table Bellicum Pharmaceuticals Company Details Table Bellicum Pharmaceuticals Revenue in Gene Modifying Immunotherapy for Blood Cancer Business 2014-2019 (Million US$) Figure Bellicum Pharmaceuticals Revenue Growth Rate in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019) Table Bellicum Pharmaceuticals Recent Development Table Mustang Bio Company Details Table Mustang Bio Revenue in Gene Modifying Immunotherapy for Blood Cancer Business 2014-2019 (Million US$) Figure Mustang Bio Revenue Growth Rate in Gene Modifying Immunotherapy for Blood Cancer Business (2014-2019) Table Mustang Bio Recent Development Table Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Regions (Million US$) 2019-2025 Figure Global Gene Modifying Immunotherapy for Blood Cancer Market Size Share by Regions (2019-2025) Figure Global Gene Modifying Immunotherapy for Blood Cancer Market Size Share by Regions in 2025 Figure North America Gene Modifying Immunotherapy for Blood Cancer Market Size Forecast (2019-2025)(Million USD) Figure Europe Gene Modifying Immunotherapy for Blood Cancer Market Size Forecast (2019-2025)(Million USD) Figure China Gene Modifying Immunotherapy for Blood Cancer Market Size Forecast (2019-2025)(Million USD) Figure Japan Gene Modifying Immunotherapy for Blood Cancer Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Gene Modifying Immunotherapy for Blood Cancer Market Size Forecast (2019-2025)(Million USD) Figure India Gene Modifying Immunotherapy for Blood Cancer Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Gene Modifying Immunotherapy for Blood Cancer Market Size Forecast (2019-2025)(Million USD) Table Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Product (2019-2025) (Million US$) Figure Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Product (2019-2025) Figure Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Product in 2025 Table Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2019-2025) (Million US$) Figure Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Application (2019-2025) Figure Global Gene Modifying Immunotherapy for Blood Cancer Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Novartis Kite Pharma Juno Therapeutics Cellectis Ziopharm Oncology Celyad Bluebird Bio Bellicum Pharmaceuticals Mustang Bio